HealthcareServices

Polymerase Chain Reaction (PCR) Market Trends 2025–2029: Forecasts for Key Growth Segments

November 26, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Does The Market Size Of The Polymerase Chain Reaction (PCR) Industry Compare Between 2025 And 2029?

The polymerase chain reaction (pcr) market has experienced rapid expansion in recent years. It is projected to increase from $11.42 billion in 2024 to $12.57 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 10.1%. The expansion observed in the past can be attributed to a rising number of research facilities, an increasing count of patients with chronic and infectious diseases, the growing prevalence of genetic and chronic disorders, an expanding global population, and a burgeoning geriatric population.

The polymerase chain reaction (pcr) market is projected to undergo significant expansion in the coming years, with its value set to reach $18.27 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 9.8%. This anticipated growth can be linked to increasing anxieties regarding food safety, the escalating requirement for secure and premium food products, the growing need for molecular diagnostics, the demand for individualized medicine, and a heightened focus on digital polymerase chain reaction (dPCR). Noteworthy trends during this forecast period encompass real-time polymerase chain reaction, advancements in DNA sequencing technologies, improvements in diagnostic testing, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and the development of sophisticated molecular diagnostic solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15638&type=smp

Which Major Market Drivers Are Shaping The Future Of The Polymerase Chain Reaction (PCR) Market?

The increasing requirement for personalized medicine is anticipated to drive the expansion of the polymerase chain reaction (PCR) market moving forward. Personalized medicine, alternatively known as precision medicine, represents a healthcare methodology that customizes medical decisions, practices, interventions, and treatments to the distinct characteristics of each individual patient. The demand for personalized medicine is on the rise due to advancements in data analytics, patient-specific treatment responses, and the capability to adapt therapies based on individual genetic profiles. Polymerase Chain Reaction (PCR) supports personalized medicine by allowing for the amplification and analysis of specific genetic sequences, thereby enabling clinicians to tailor treatment plans according to a patient’s unique genetic makeup. For instance, the Personalized Medicine Coalition, a US-based professional membership organization, reported that in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, indicating a considerable increase from previous years. Hence, the growing demand for personalized medicine is a primary factor fueling the growth of the polymerase chain reaction market.

What Are The Key Segments In The Polymerase Chain Reaction (PCR) Market?

The polymerase chain reaction (pcr)market covered in this report is segmented –

1) By Type: Conventional Polymerase Chain Reaction; Other Types

2) By Indication: Infectious Diseases; Oncology; Genetic Disorders; Other Indications

3) By Application: Medical; Non-Medical

4) By End User: Hospitals And Clinics; Pharmaceutical And Biotechnology Industries; Diagnostic Centers; Academic And Research Organization

Subsegments:

1) By Conventional Polymerase Chain Reaction: Endpoint Pcr; Gel Electrophoresis-Based Pcr; Reverse Transcription Pcr (Rt-Pcr); Quantitative Pcr (Qpcr) For Gene Expression; Nested Pcr

2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr); Digital Pcr (Dpcr); Multiplex Pcr; Reverse Transcription-Quantitative Pcr (Rt-Qpcr); Isothermal Amplification (Lamp); Next-Generation Pcr (Ngs-Based Pcr Techniques); High-Throughput Pcr

What Are The Major Trends Driving The Growth Of The Polymerase Chain Reaction (PCR) Market?

Companies active in the polymerase chain reaction market are focusing on creating real-time polymerase chain reaction test kits to improve the precision, effectiveness, and ease of use in genetic analysis. Real-time polymerase chain reaction (RT-PCR) is a laboratory-developed diagnostic method utilized for the immediate amplification and measurement of specific DNA sequences. For example, in November 2022, Cepheid, a molecular diagnostics company based in the US, unveiled its Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test capable of detecting DNA from organisms linked to three separate vaginal infections—bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis—from just one vaginal swab sample. This technology advances traditional polymerase chain reaction methods by enabling real-time observation, quantification, and providing increased sensitivity and specificity, thereby making it an indispensable instrument in molecular biology and clinical diagnostics.

Who Are The Major Companies Operating In The Polymerase Chain Reaction (PCR) Market?

Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reaction-pcr-global-market-report

Which Region Is Expected To Witness The Fastest Growth In The Polymerase Chain Reaction (PCR) Market?

North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Polymerase Chain Reaction (PCR) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=15638&type=smp

Browse Through More Reports Similar to the Global Polymerase Chain Reaction (PCR) Market 2025, By The Business Research Company

Polymerase Chain Reactions Devices Reagents And Uses Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/polymerase-chain-reactions-devices-reagents-and-uses-global-market-report

Blockchain Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blockchain-technologies-global-market-report

Blockchain Services Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/blockchain-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795